During the past decade, USF Health conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 7 clinical trials were completed, i.e. on average, 43.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "USF Health" #1 sponsor was "University of South Florida" with 3 trials, followed by "Knopp Biosciences" with 2 trials sponsored, "Newron Pharmaceuticals SPA" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Takeda" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "USF Health" #1 collaborator was "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Advanced Clinical Research Services, LLC" with 1 trials as a collaborator, "Bio-Medical Research, Ltd." with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "EMD Serono" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "USF Health" are "Amyotrophic Lateral Sclerosis" (2 trials), "Idiopathic Parkinson's Disease" (2 trials), "Adnexal Mass" (1 trials), "Cholestasis" (1 trials) and "Cholestasis of Parenteral Nutrition" (1 trials). Many other conditions were trialed in "USF Health" in a lesser frequency.

Most popular intervention types in "USF Health" are "Drug" (16 trials), "Device" (5 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Dexpramipexole" (2 trials), "ARRY-371797 (PF-07265803)" (1 trials), "Alogliptin Benzoate" (1 trials) and "Apremilast" (1 trials). Other intervention names were less common.

The vast majority of trials in "USF Health" are 23 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "USF Health". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in USF Health, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in USF Health, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".